Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, Presbyterian Hospital 9th Floor, Suite 105, New York, NY 10032, USA.
Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Eur Heart J. 2022 Jun 14;43(23):2196-2208. doi: 10.1093/eurheartj/ehac205.
The aim is to evaluate associations of lung function impairment with risk of incident heart failure (HF).
Data were pooled across eight US population-based cohorts that enrolled participants from 1987 to 2004. Participants with self-reported baseline cardiovascular disease were excluded. Spirometry was used to define obstructive [forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) <0.70] or restrictive (FEV1/FVC ≥0.70, FVC <80%) lung physiology. The incident HF was defined as hospitalization or death caused by HF. In a sub-set, HF events were sub-classified as HF with reduced ejection fraction (HFrEF; EF <50%) or preserved EF (HFpEF; EF ≥50%). The Fine-Gray proportional sub-distribution hazards models were adjusted for sociodemographic factors, smoking, and cardiovascular risk factors. In models of incident HF sub-types, HFrEF, HFpEF, and non-HF mortality were treated as competing risks. Among 31 677 adults, there were 3344 incident HF events over a median follow-up of 21.0 years. Of 2066 classifiable HF events, 1030 were classified as HFrEF and 1036 as HFpEF. Obstructive [adjusted hazard ratio (HR) 1.17, 95% confidence interval (CI) 1.07-1.27] and restrictive physiology (adjusted HR 1.43, 95% CI 1.27-1.62) were associated with incident HF. Obstructive and restrictive ventilatory defects were associated with HFpEF but not HFrEF. The magnitude of the association between restrictive physiology and HFpEF was similar to associations with hypertension, diabetes, and smoking.
Lung function impairment was associated with increased risk of incident HF, and particularly incident HFpEF, independent of and to a similar extent as major known cardiovascular risk factors.
评估肺功能损害与心力衰竭(HF)发病风险的相关性。
本研究汇总了 8 项美国基于人群的队列研究的数据,这些研究的参与者于 1987 年至 2004 年期间入组。排除了有心血管疾病基线报告的参与者。使用肺量测定法定义阻塞性(1 秒用力呼气量/用力肺活量[FEV1/FVC]<0.70)或限制性(FEV1/FVC≥0.70,FVC<80%)肺生理学。新发 HF 定义为 HF 导致的住院或死亡。在一个子集中,HF 事件被细分为射血分数降低的 HF(HFrEF;EF<50%)或保留射血分数的 HF(HFpEF;EF≥50%)。Fine-Gray 比例亚分布风险模型调整了社会人口统计学因素、吸烟和心血管危险因素。在新发 HF 亚型的模型中,HFrEF、HFpEF 和非 HF 死亡率被视为竞争风险。在 31677 名成年人中,中位随访 21.0 年后共发生 3344 例新发 HF 事件。在可分类的 2066 例 HF 事件中,1030 例被归类为 HFrEF,1036 例归类为 HFpEF。阻塞性(调整后的风险比[HR]1.17,95%置信区间[CI]1.07-1.27)和限制性生理学(调整后的 HR 1.43,95%CI 1.27-1.62)与新发 HF 相关。阻塞性和限制性通气缺陷与 HFpEF 相关,但与 HFrEF 无关。限制性生理学与 HFpEF 之间的关联程度与高血压、糖尿病和吸烟等主要心血管危险因素相似。
肺功能损害与 HF 发病风险增加相关,特别是与 HFpEF 相关,且与主要已知心血管危险因素的相关性独立且程度相似。